Evidence map›Paper›PMID 31463540›Full record

ArticleEuropean biophysics journal : EBJ2019

Enzymatic activity of human immunodeficiency virus type 1 protease in crowded solutions.

Ksenia Maximova, Jakub Wojtczak, Joanna Trylska

Open access · hybridAbstract read
In one paragraph

Article in European biophysics journal : EBJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mechanisms and Effects of Substrate Channelling in Enzymatic Cascades.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  5. A genetically encoded BRET-based SARS-CoV-2 MCommunications chemistry · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ksenia MaximovaCentre of New Technologies, University of Warsaw, Banacha 2C, 02-097, Warsaw, Poland. k.maximova@cent.uw.edu.pl.ORCID http://orcid.org/0000-0003-4763-5698
Jakub WojtczakCentre of New Technologies, University of Warsaw, Banacha 2C, 02-097, Warsaw, Poland.
Joanna TrylskaCentre of New Technologies, University of Warsaw, Banacha 2C, 02-097, Warsaw, Poland. joanna@cent.uw.edu.pl.ORCID http://orcid.org/0000-0002-1464-5323
University of Warsaw · PLWarsaw University of Technology · PL

Funding

National Science Centre, Poland UMO-2016/23/B/NZ1/03198
6 · The paper itself

Abstract

Cells are crowded with various macromolecules and metabolites, which affect biochemical reactions in many ways, from the diffusion of substrates to catalytic activities of enzymes. We herein investigated the proteolytic activity of the human immunodeficiency virus type 1 protease (HIV-1 PR) under non-crowded and crowded conditions. The latter environment was mimicked with various (poly)ethylene glycol molecules as crowding agents. We found that these crowding agents affect the kinetic parameters of the HIV-1 PR catalyzed reaction by increasing the Michaelis-Menten constant and decreasing the maximum velocity. The influence of crowding was concentration dependent. We explain this effect by the dynamics of the HIV-1 PR flexible flaps that cover the peptide substrate binding site and are crucial for enzyme activity, and by a possibly slower substrate-enzyme association time in the crowded conditions.

Indexed as

BiocatalysisHIV-1HIV ProteaseHydrolysisKineticsModels, MolecularProtein Structure, TertiarySolutionsHIV ProteaseSolutionsCrowded environmentEnzymatic reactionsFluorescence spectroscopyHuman immunodeficiency virus type 1 protease (HIV-1 PR)Kinetic parametersPolyethylene glycol

Identifiers

PMID31463540
PMCPMC6742607
OpenAlexW2970750990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.